MedPath

SERB SA

🇧🇪Belgium
Ownership
Holding
Employees
-
Market Cap
-
Website
http://serb.eu

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

CIMA_AEMPS:5
EMA:4

Drug Approvals

Amifampridine SERB

Authorization Status
Authorised
Approval Date
May 19, 2022
EMA

Amversio

Authorization Status
Authorised
Approval Date
May 5, 2022
EMA

Firdapse (previously Zenas)

Authorization Status
Authorised
Approval Date
Dec 23, 2009
EMA

Cyanokit

Authorization Status
Authorised
Approval Date
Nov 23, 2007
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.